PLYX Polaryx Therapeutics, Inc.
Fundamentals / CIK 0002075320 / USDPolaryx Therapeutics, Inc. reported $8.61M in total assets and a net loss of $8.75M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PLYX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$7.58M Operating profit
-
Net Income FY 2025-$8.75M GAAP bottom line
-
Diluted EPS FY 2025-$0.18 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$8.44M Total debt: --
Annual revenue and net income
2 fiscal years (2024 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 |
|---|---|---|
| Research & Development | $6.27M | $2.81M |
| Total Operating Expenses | $7.82M | $4.35M |
| Operating Income | -$7.82M | -$4.35M |
| Income Before Tax | -$8.98M | -$30.36M |
| Net Income | -$8.98M | -$30.36M |
| Basic EPS | -$0.20 | -$0.89 |
| Diluted EPS | -$0.20 | -$0.89 |
| Basic Shares Outstanding | 45.4M | 34.2M |
| Diluted Shares Outstanding | 45.4M | 34.2M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Research & Development | $2.45M | $719K | $679K | $560K | $514K | $476K | $4.72M |
| Total Operating Expenses | $3.33M | $1.38M | $1.96M | $911K | $974K | $884K | $5.05M |
| Operating Income | -$3.33M | -$1.38M | -$1.96M | -$911K | -$974K | -$884K | -$5.05M |
| Net Income | -$3.33M | -$1.38M | -$2.54M | -$1.50M | -$1.43M | -$1.01M | -$5.05M |
| Basic EPS | -$0.07 | -$0.03 | -$0.05 | -- | -$0.03 | -$0.02 | -$0.11 |
| Diluted EPS | -$0.07 | -$0.03 | -$0.05 | -- | -$0.03 | -$0.02 | -$0.11 |
| Basic Shares Outstanding | 49.8M | 48.3M | 47.2M | -- | 45.8M | 44.7M | 44.3M |
| Diluted Shares Outstanding | 49.8M | 48.3M | 47.2M | -- | 45.8M | 44.7M | 44.3M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 |
|---|---|---|
| Cash & Cash Equivalents | $5.14M | $4.62M |
| Cash & Short-Term Investments | $5.14M | $4.62M |
| Other Current Assets | $27K | -- |
| Total Current Assets | $5.17M | $5.00M |
| Total Non-Current Assets | $0 | $0 |
| Total Assets | $5.17M | $5.00M |
| Accounts Payable | $470K | $72K |
| Total Current Liabilities | $605K | $289K |
| Total Non-Current Liabilities | $0 | $0 |
| Total Liabilities | $605K | $289K |
| Common Stock | $5.0K | $4.0K |
| Retained Earnings | -$99.64M | -$90.65M |
| Total Stockholders' Equity | $4.57M | $4.71M |
| Total Equity | $4.57M | $4.71M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $8.44M | $11.54M | $3.08M | $5.14M | $4.62M |
| Cash & Short-Term Investments | $8.44M | $11.54M | $3.08M | $5.14M | $4.62M |
| Other Current Assets | $18K | -- | $33K | $27K | -- |
| Total Current Assets | $8.61M | $11.81M | $3.50M | $5.17M | $5.00M |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $8.61M | $11.81M | $3.50M | $5.17M | $5.00M |
| Accounts Payable | $783K | $683K | $850K | $470K | $72K |
| Total Current Liabilities | $999K | $873K | $1.01M | $605K | $289K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $999K | $873K | $1.01M | $605K | $289K |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K |
| Retained Earnings | -$106.9M | -$103.6M | -$102.2M | -$99.64M | -$90.65M |
| Total Stockholders' Equity | $7.61M | $10.94M | $2.49M | $4.57M | $4.71M |
| Total Equity | $7.61M | $10.94M | $2.49M | $4.57M | $4.71M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 |
|---|---|---|
| Net Income | -$8.98M | -$30.36M |
| Stock-Based Compensation | $4.72M | $2.40M |
| Change in Payables | $398K | -$401K |
| Operating Cash Flow | -$3.94M | -$2.57M |
| Common Stock Issued | $4.49M | $7.32M |
| Financing Cash Flow | $4.47M | $7.19M |
| Net Change in Cash | $522K | $4.62M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$3.33M | -$1.38M | -$2.54M | -$1.50M | -$1.43M | -$1.01M | -$5.05M |
| Stock-Based Compensation | $0 | $0 | $467K | $57K | $108K | $109K | $4.45M |
| Change in Payables | $100K | -$167K | $380K | -$26K | $338K | $103K | -$17K |
| Operating Cash Flow | -$3.10M | -$1.37M | -$2.06M | -$1.49M | -$887K | -$858K | -$709K |
| Common Stock Issued | -- | -- | -- | $759K | $3.48M | $0 | $250K |
| Financing Cash Flow | -- | -- | -- | $888K | $3.33M | $0 | $250K |
| Net Change in Cash | -$3.10M | $8.46M | -$2.06M | -$602K | $2.44M | -$858K | -$459K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 |
|---|---|---|
| Return on Equity (ROE) | -196.8% | -644.2% |
| Return on Assets (ROA) | -173.8% | -607.0% |
| Current Ratio | 8.55x | 17.30x |
| Quick Ratio | 8.50x | 15.99x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -114.9% | -62.6% | -260.3% | -196.8% | -- | -- | -- |
| Return on Assets (ROA) | -101.6% | -58.0% | -185.0% | -173.8% | -- | -- | -- |
| Current Ratio | 8.62x | 13.53x | 3.45x | 8.55x | -- | -- | -- |
| Quick Ratio | 8.45x | 13.22x | 3.04x | 8.50x | -- | -- | -- |